Head and neck cancer
Invited discussant abstract 315O
Date
18 Dec 2015Session
Head and neck cancerPresenters
Brigette B MaAuthors
B.B. MaAuthor affiliations
- Department Of Clinical Oncology, Prince of Wales Hospital, Hong Kong/CN
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
693 - Second-line afatinib vs methotrexate (MTX) in patients (pts) with recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC): subgroup/biomarker analysis of LUX-head and neck 1 (LUX-H&N1)
Presenter: Makoto Tahara
Session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
Invited discussant abstract 314O
Presenter: Fortunato Ciardiello
Session: Head and neck cancer
Resources:
Webcast
Early or delayed use of TKI
Presenter: Makoto Tahara
Session: Head and neck cancer
Resources:
Slides
Webcast
1230 - Antitumor activity and safety of pembrolizumab in patients with PD-L1-positive nasopharyngeal carcinoma: Interim results from a phase 1b study
Presenter: Chiun Hsu
Session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.